Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

about

The Cooperative Effect of Genistein and Protein Hydrolysates on the Proliferation and Survival of Osteoblastic Cells (hFOB 1.19).

P2860

Q38731787-9435AA2C-0AC6-4C1A-8B99-B016013DA28F

P2860

Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

Item

http://www.wikidata.org/entity/Q36388438

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

@ast

Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

@en

type

Item

label

Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

@ast

Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

@en

prefLabel

Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

@ast

Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

@en

P1476

Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

@en

P2093

Hyung Kwan Kim

http://www.w3.org/2001/XMLSchema#string

Ji-Young Imm

http://www.w3.org/2001/XMLSchema#string

Jonggun Kim

http://www.w3.org/2001/XMLSchema#string

Kwang-Youn Whang

http://www.w3.org/2001/XMLSchema#string

Saehun Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Histochemical demonstration of acid phosphatase activity in osteoclasts

Bone-alkaline phosphatase as indicator of bone formation

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

Effects of estradiol and progesterone on body composition, protein synthesis, and lipoprotein lipase in rats.

Importance of preclinical studies in the development of drugs for treatment of osteoporosis: a review related to the 1998 WHO guidelines.

17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism.

Osteoporosis prevention, diagnosis, and therapy.

Involutional osteoporosis.

Risedronate: a review of its pharmacological properties and clinical use in resorptive bone disease.

Alendronate: an update of its use in osteoporosis.

P304

1349-1356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/JMF.2015.3441

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26367331

http://www.w3.org/2001/XMLSchema#string

P932

4685489

http://www.w3.org/2001/XMLSchema#string

Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

about

P2860

P2860

Whey Protein Concentrate Hydrolysate Prevents Bone Loss in Ovariectomized Rats

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932